z-logo
open-access-imgOpen Access
Is serum FGF-23 associated with subclinic atherosclerosis in patients with AA amyloidosis?
Author(s) -
Ali Bakan,
Alihan Oral,
Abdullah Özkök,
Sabahat Alışır Ecder,
Ömer Celal Elçioğlu,
Gülşah Şaşak Kuzgun,
Kübra Aydın,
Ali Rıza Odabaş
Publication year - 2019
Publication title -
i̇stanbul kanuni sultan süleyman tıp dergisi
Language(s) - English
Resource type - Journals
eISSN - 2667-7458
pISSN - 2148-273X
DOI - 10.5222/iksstd.2019.77486
Subject(s) - amyloidosis , medicine , gastroenterology , fibroblast growth factor , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom